Literature DB >> 11553181

Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).

A Vaag1, M Lehtovirta, P Thye-Rönn, L Groop.   

Abstract

BACKGROUND: Insulin resistance was found in some but not in all previous studies of non-diabetic first degree relatives of Type 2 diabetic patients. Small study groups, ethnic differences and/or non-optimal techniques may explain the conflicting results. AIM: To study the impact of a family history of Type 2 diabetes on insulin action in a large group of non-diabetic Europeans using the 'gold standard' euglycaemic hyperinsulinaemic clamp technique.
METHODS: Non-diabetic subjects (n = 235) with a positive family history of Type 2 diabetes (FH+) and 564 subjects with no family history of diabetes (FH-) were recruited from The European Group of Insulin Resistance (EGIR) database. This database includes measurements of insulin action using the insulin clamp technique (1 mU/kg per min) in normal glucose-tolerant individuals from 20 different European centres. In a subset of subjects the measurements were performed in combination with indirect calorimetry (n = 80 vs. 213 with and without family history of Type 2 diabetes).
RESULTS: The body mass index (BMI) was slightly higher in FH+ compared with FH- (26.7 +/- 4.6 vs. 25.1 +/- 4.7 kg/m(2); P < 0.02). After correction for covariates according to differences between investigators and subject characteristics including BMI (multiple regression analysis), insulin-stimulated glucose disposal was lower in FH+ compared with FH- (P < 0.00001). Insulin-stimulated glucose oxidation was slightly increased in FH+ compared with FH-, and insulin-stimulated non-oxidative glucose metabolism was consequently markedly reduced in FH+ compared with FH- (P < 0.0005).
CONCLUSION: Insulin resistance is present in European non-diabetic relatives of Type 2 diabetic patients. The insulin resistance is independent of degree of obesity and is restricted solely to the pathway of non-oxidative glucose metabolism. Diabet. Med. 18, 533-540 (2001)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553181     DOI: 10.1046/j.1464-5491.2001.00496.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  15 in total

1.  A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study.

Authors:  B Isomaa; B Forsén; K Lahti; N Holmström; J Wadén; O Matintupa; P Almgren; J G Eriksson; V Lyssenko; M-R Taskinen; T Tuomi; L C Groop
Journal:  Diabetologia       Date:  2010-05-08       Impact factor: 10.122

2.  Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects.

Authors:  T E Graham; C J Wason; M Blüher; B B Kahn
Journal:  Diabetologia       Date:  2007-02-09       Impact factor: 10.122

3.  Parental History of Type 2 Diabetes Abrogates Ethnic Disparities in Key Glucoregulatory Indices.

Authors:  Ebenezer Nyenwe; Ibiye Owei; Jim Wan; Sam Dagogo-Jack
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

4.  Maternal and paternal family history of type 2 diabetes differently influence lipid parameters in young nondiabetic Japanese women.

Authors:  Kemal Sasaki; Aya Yoshida; Hiroshi Ohta; Yoshiharu Aizawa; Akiko Kojima; Hitomi Chiba; Shin Mizuguchi; Tatsunori Ishidzuka; Hiroshi Goto; Chiho Uegaki; Kyuhei Kotake
Journal:  Environ Health Prev Med       Date:  2012-07-25       Impact factor: 3.674

5.  Sympathetic nerve hyperactivity in non-diabetic offspring of patients with type 2 diabetes mellitus.

Authors:  R J Huggett; A J Hogarth; A F Mackintosh; D A S G Mary
Journal:  Diabetologia       Date:  2006-09-13       Impact factor: 10.122

6.  Racial differences in peripheral insulin sensitivity and mitochondrial capacity in the absence of obesity.

Authors:  James P DeLany; John J Dubé; Robert A Standley; Giovanna Distefano; Bret H Goodpaster; Maja Stefanovic-Racic; Paul M Coen; Frederico G S Toledo
Journal:  J Clin Endocrinol Metab       Date:  2014-08-08       Impact factor: 5.958

7.  The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives.

Authors:  S A Hills; B Balkau; S W Coppack; J M Dekker; A Mari; A Natali; M Walker; E Ferrannini
Journal:  Diabetologia       Date:  2004-02-14       Impact factor: 10.122

8.  Changes in insulin secretion and action in adults with familial risk for type 2 diabetes who curtail their sleep.

Authors:  Amy Darukhanavala; John N Booth; Lindsay Bromley; Harry Whitmore; Jacqueline Imperial; Plamen D Penev
Journal:  Diabetes Care       Date:  2011-08-11       Impact factor: 19.112

9.  Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?

Authors:  Rezvan Salehidoost; Ashraf Aminorroaya; Maryam Zare; Massoud Amini
Journal:  J Res Med Sci       Date:  2012-11       Impact factor: 1.852

10.  Maternal history of diabetes is associated with increased cardiometabolic risk in Chinese.

Authors:  C H T Tam; Y Wang; J Luan; H M Lee; A O Y Luk; G E Tutino; P C Y Tong; A P S Kong; W Y So; J C N Chan; R C W Ma
Journal:  Nutr Diabetes       Date:  2014-03-10       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.